Review summary (print version)Background Fast-spiking, parvalbumin-expressing interneurons (PV + interneurons) play a key role in several functions of the brain. They contribute to feedback and feedforward inhibition, and are critically involved in the generation of network oscillations. A hallmark property of these interneurons is speed. In essence, these cells convert an excitatory input signal into an inhibitory output signal within a millisecond. How these remarkable signaling properties are implemented at the molecular and cellular level has been unclear. Furthermore, how PV + interneurons shape complex network functions has remained an open question.
Advances
Outlook
PV+ interneurons may also play a key role in numerous brain diseases. These include epilepsy, but also complex psychiatric diseases, such as schizophrenia. Thus, PV + interneurons may become important therapeutic targets in the future. However, much needs to be learned about the basic function of these interneurons before clinical neuroscientists will have a chance to successfully use PV + interneurons for therapeutic purposes.
3
Full article (online) AbstractThe success story of fast-spiking, parvalbumin-expressing (PV + ) GABAergic interneurons is amazing. In 1995, the properties of these interneurons were completely unknown. 20 years later, thanks to the massive use of subcellular patchclamp techniques, simultaneous multiple-cell recording, optogenetics, in vivo measurements, and computational approaches, our knowledge about PV + interneurons became more extensive than for several types of pyramidal neurons (Box 1). These findings have implications beyond the "small world" of basic research on GABAergic cells. For example, the results provide a first proof of principle that neuroscientists might be able to close the gaps between molecular, cellular, network, and behavioral level, which represents one of the main challenges at the present time. Furthermore, the results may form the basis for using PV + interneurons as therapeutical targets for brain diseases in the future. However, much needs to be learned about the basic function of these interneurons before clinical neuroscientists will be able to use PV + interneurons for therapeutic purposes.